Peak Hours News
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Economy

DOJ sues Walgreens, alleging it ‘knowingly’ filled millions of invalid prescriptions

by January 19, 2025
written by January 19, 2025

The Department of Justice said Friday that it sued pharmacy giant Walgreens over allegedly dispensing millions of unlawful prescriptions.

The DOJ said that Walgreens from August 2012 until the present “knowingly” filled those prescriptions, which “lacked a legitimate medical purpose, were not valid, and/or were not issued in the usual course of professional practice.” 

“This lawsuit seeks to hold Walgreens accountable for the many years that it failed to meet its obligations when dispensing dangerous opioids and other drugs,” said Principal Deputy Assistant Attorney General Brian Boynton, head of the DOJ’s Civil Division.

Boynton said that Walgreens pharmacists filled millions of prescriptions with “clear red flags that indicated the prescriptions were highly likely to be unlawful.”

The company “systematically pressured its pharmacists to fill prescriptions, including controlled substance prescriptions, without taking the time needed to confirm their validity,” Boynton said. “These practices allowed millions of opioid pills and other controlled substances to flow illegally out of Walgreens stores.”

Some Walgreens patients died of overdose deaths shortly after getting invalid prescriptions filled at Walgreens, the DOJ alleges.

The 300-page lawsuit was filed Thursday in U.S. District Court in Chicago.

Walgreens in a statement said, “We are asking the court to clarify the responsibilities of pharmacies and pharmacists and to protect against the government’s attempt to enforce arbitrary ‘rules’ that do not appear in any law or regulation and never went through any official rulemaking process.”

“We will not stand by and allow the government to put our pharmacists in a no-win situation, trying to comply with ‘rules’ that simply do not exist,” Walgreens said.

“Walgreens stands behind our pharmacists, dedicated healthcare professionals who live in the communities they serve, filling legitimate prescriptions for FDA-approved medications written by DEA-licensed prescribers in accordance with all applicable laws and regulations.”

The suit alleges that although Walgreens issued written policies that reflected its understanding of legal obligations, the company took other actions which it knew prevented its pharmacists from complying with them.

“Walgreens prioritized profits over safety and compliance by implementing policies and practices that required pharmacists to fill prescriptions quickly and left pharmacists without enough time or resources to exercise their corresponding responsibility,” the suit said.

“One such metric was ‘Verify By Promise Time’ (VBPT), which expected a pharmacist to fill a prescription within 15 minutes for a ‘waiter’ (a customer waiting in the pharmacy store for the prescription),” the suit alleges.

“Walgreens also tracked pharmacists that dispensed a low rate of controlled substances through its ‘Non-dispensing Pharmacist Report,’” the suit said.

“Walgreens created this metric in part because it believed pharmacists who refused to fill controlled-substance prescriptions compromised Walgreens’s customer service.”

This post appeared first on NBC NEWS

0 comment
0
FacebookTwitterPinterestEmail

previous post
IMF’s board approves second review of Ethiopia’s $3.4 billion program
next post
Israel stocks higher at close of trade; TA 35 up 1.07%

You may also like

October monthly job cuts surged to a 22-year...

November 7, 2025

Yum Brands begins strategic review for struggling Pizza...

November 5, 2025

Kimberly-Clark to buy Kenvue in $48.7 billion deal

November 4, 2025

Barbie, Monopoly toymakers see bright holiday season despite...

October 29, 2025

Target is eliminating 1,800 corporate jobs as it...

October 25, 2025

Trump’s Argentina beef import plan will harm U.S....

October 24, 2025

Travis Kelce part of investor group aiming to...

October 24, 2025

X-ray tables, hidden cameras: The tech in rigged...

October 24, 2025

Customers sue sneaker company On over shoes that...

October 20, 2025

Giorgio Armani group names longtime executive Giuseppe Marsocci...

October 18, 2025
Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.









    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • How billionaire Caltagirone could influence Italy’s banking M&A wave

      November 9, 2025
    • How billionaire Caltagirone could influence Italy’s banking M&A wave

      November 8, 2025
    • How billionaire Caltagirone could influence Italy’s banking M&A wave

      November 7, 2025
    • October monthly job cuts surged to a 22-year high

      November 7, 2025
    • How billionaire Caltagirone could influence Italy’s banking M&A wave

      November 6, 2025

    Categories

    • Economy (652)
    • Editor's Pick (10)
    • Investing (1,037)
    • Stock (798)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: peakhoursnews.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Back To Top
    Peak Hours News
    • Investing
    • Stock
    • Economy
    • Editor’s Pick